Filing Details

Accession Number:
0000905148-24-001568
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-21 16:18:02
Reporting Period:
2024-05-17
Accepted Time:
2024-05-21 16:18:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1228627 Ocuphire Pharma Inc. OCUP Pharmaceutical Preparations (2834) 113516358
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1999390 George Magrath C/O Ocuphire Pharma, Inc.
37000 Grand River Ave, Suite 120
Farmington Hills MI 48335
Chief Executive Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-17 5,000 $1.75 430,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price in column 4 represents the weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.73 to $1.78, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.